• Home
  • Technology
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • Investors
  • Contact Us
Regentis Biomaterials Logo
Regentis Biomaterials Logo
  • HOME
  • TECHNOLOGY
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • INVESTORS
  • CONTACT US

Investor Relations

Contact IR

☰  IR MENU
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts

Contact Us

Thank you for contacting us.
We will get back to you as soon as possible.
Oops, there was an error sending your message.
Please try again later.

Get in Touch

60, Medinat Hyahudim
Entrance C
Herzlia Pituach, Israel 4676652


For general inquiries:
Dr. Ehud Geller +972-9-960-1917
Email: egeller@medicavp.com

Security holders may request a hard copy of Regentis’s Annual Report, including its complete audited consolidated financial statements, free of charge, to its shareholders upon request to Regentis Investor Relations at 60 Medinat Hayehudim Street, 4676652, Israel or by phone at +972 (9) 960-1917. 

© 2026 Regentis Biomaterials. All Rights Reserved
|
Terms of Use
|
Privacy Policy
|
Accessibility Declaration
|
Sitemap
|
Powevered by ACCESS Newswire
Share by: